Today's News | Note: News feeds may no longer be available for the articles on this page.

Wyeth buys tiny biotech focused on obesity 5:38 AM 12/18/2008
Reuters - USA
Wyeth paid $30 million to acquire privately held Thiakis Ltd and its experimental obesity drug TKS1225 in early-stage human studies. TKS1225 and related compounds are synthetic versions of a peptide found in the gastrointestinal system. ...

US orders suicidal action warning on epilepsy drugs 5:08 AM 12/18/2008
Reuters - USA
Pfizer's Lyrica and Neurontin, GlaxoSmithKline's Lamictal, and Johnson & Johnson's Topamax must carry a warning that the medicines increase the chances of suicidal thoughts or actions. ...

Health, emergency staff get drugs 1st in pandemic 4:33 AM 12/18/2008
Reuters - USA
US DHHS said health care and emergency services workers who might get sick during an influenza pandemic should take antiviral drugs throughout the epidemic. ...

Cadence's pain drug meets main goal; shares jump 2:32 AM 12/18/2008
Reuters - USA
Cadence Pharmaceuticals' painkiller Acetavance met the main goal of a last-stage trial. ...

Abbott to buy Isis unit for $215 million total payment 4:08 PM 12/17/2008
MarketWatch - USA
Abbott has exercised its option to purchase the remaining equity ownership in Ibis Biosciences Inc. The total cost for the Ibis acquisition is $215 million. ...

Dynavax signs development deal with Glaxo 8:34 AM 12/17/2008
CNNMoney.com - USA
Dynavax Technologies Corp will receive up to $800 million over time from GlaxoSmithKline to develop autoimmune and inflammatory disease treatments for lupus, psoriasis, and rheumatoid arthritis. ...

Bristol-Myers Squibb to shed 800 more positions 6:24 AM 12/17/2008
Boston Globe - United States
Drug maker will eliminate another 10 percent of its workforce through 2010 before it loses patent protection on key drugs. ...

Anesiva's pain drug meets main goal; shares zoom 12:27 PM 12/16/2008
Reuters - USA
Anesiva Inc's experimental pain drug Adlea met the main goal of a late-stage trial. The biopharmaceutical company may now find a partner to further develop the drug. ...

Deutsche Analyst Sees Pfizer Going After Amgen 11:56 AM 12/16/2008
CNNMoney.com - USA
Pfizer may lead the charge in drug-industry consolidation by trying to acquire a large biotechnology company like Amgen Inc. ...

MS drug Tysabri may promote brain infection-study 11:21 AM 12/16/2008
Reuters - USA
Multiple sclerosis drug Tysabri (natalizumab) appears to promote a rare brain infection by suppressing the brain's immune system cells. The drug might be safer if treatment breaks allow immune recovery. ...

Lilly, Amgen: data backs cancer drug use with normal gene 10:26 AM 12/16/2008
Reuters - USA
ImClone Systems and Amgen Inc say they have enough data to show their colon cancer drugs Erbitux and Vectibix help those with a normal version of a certain gene. ...

Genzyme gets FDA OK on stem cell transplant drug 7:42 AM 12/16/2008
Forbes - NY,USA
The US FDA has approved Genzyme Corp's stem cell transplant drug Mozobil with special status protecting it from competition for seven years. The drug helps move hematopietic stem cells from bone marrow to bloodstream where they can be collected. ...

FDA approves Abbott Laboratories' cholesterol drug TriLipix 6:08 AM 12/16/2008
Los Angeles Times - CA,USA
The US FDA has approved TriLipix shown in studies to reduce artery-clogging cholesterol and fat in patients' blood when used with statins. ...

Chugai to seek Japan approval of osteoporosis drug 5:07 AM 12/16/2008
Reuters - USA
Chugai Pharmaceutical and Taisho Pharmaceutical will seek approval in Japan for vitamin D derivative and drug candidate eledecalcitol for osteoporosis. ...

Medicare Plans Draw Criticism on Drug Pricing 5:05 AM 12/16/2008
Wall Street Journal - USA
Reference-based pricing is used by dozens of plans offering coverage through Medicare's Part D drug-insurance program. It may force Americans to pay penalties when they choose brand-names over generics. ...

<- Day Earlier | Today's News